New mRNA Therapy Destroys Cancer by Improving T Cell Priming
Scientists have found a way to drastically ramp up mouse immune responses to cancer along with flu and COVID-19 [1]. How to wake up the immune […]

Matthew O’Connor on Cyclarity’s Successful Phase 1 Trial
Most cardiovascular trials focus on lowering LDL cholesterol or reducing inflammation to slow disease progression. UDP-003 targets the root cause: toxic 7-ketocholesterol (7KC) inside macrophages and soft plaques. It is […]

Current Clinical Trials of Alzheimer’s Drugs

GLP-1 Drugs’ Muscle Effects Similar to Ordinary Weight Loss

Junyue Cao on How the Body Ages, Cell by Cell

How Intestinal Aging Encourages Harmful Bacteria

Creatine Shows Synergy With Exercise in Older Adults

The Latest Longevity News

“Thinking” AI Outperforms Human Doctors on Real-Life Data

The Longevity Investor Network Looks Back at 2025

Rejuvenation Roundup April 2026

Some Researchers Choose Replacement Over Repair in Aging

Aging & longevity topics

Rejuvenation Biotechnology

Chondroitin Sulfate: Benefits, Side Effects, and Research

How Sleep Apnea Accelerates Biological Aging

Dysbiosis

Chronic Inflammation

Editor’s Picks – The top longevity stories

First Human Cellular Reprogramming Trial Cleared by the FDA

Longevity Advocacy in 2025: The Expert Roundup

Geroscience in 2025: The Expert Roundup

Longevity Biotech in 2025: The Expert Roundup

Industry Press Releases

Cyclarity Unveils Oxidized Cholesterol Excretion Data

Forever Healthy Releases AI4L 1.0 for Practical Longevity

Longevity Day at NFC Summit Lisbon Announces Speaker Lineup

BioAge Reports Positive Phase 1 Data for BGE-102

APLMS and Kitalys to Host Healthy Longevity in Hong Kong

Rubedo Announces Positive Preliminary Results for RLS-1496

If you would like to send the Lifespan News Team a Press release, contact news.team@lifespan.io

If you need to contact the Lifespan News Editorial team, reach out to editor@lifespan.io